MedTrace Logo

Plant Stanols and Type 1 Diabetes

NCT01205308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2012-04-17

No results posted yet for this study

Summary

In type 1 diabetes (T1D) coronary artery disease (CAD) is an important cause of morbidity and mortality. Although serum cholesterol concentrations are not always elevated in T1D, cholesterol metabolism is different from non-diabetics, so that cholesterol absorption is enhanced. The aim of this study is to investigate the effects of plant stanol esters on serum lipid and lipoprotein lipid concentrations, plant sterol and cholestanol concentrations as well as cholesterol metabolism in T1 diabetics on statin use. The study will give new information about how addition of plant stanol esters on statin use improve hypolipidemic effects in type 1 diabetes.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vegetable oil based margarine with plant stanol ester enrichment

3 g plant stanols/ day

Sponsors & Collaborators

  • Kuopio University Hospital

    collaborator OTHER

  • Raisio Plc

    collaborator INDUSTRY

  • Marjukka Kolehmainen

    lead OTHER

Principal Investigators

  • Helena Gylling, Professor · University of Eastern Finland

  • Maarit Hallikainen, PhD · University of Eastern Finland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-10-31
Completion
2011-03-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01205308 on ClinicalTrials.gov